Your trusted source for investing success

Tag: LON

Ormonde Mining: Barruecopardo Tungsten Project Construction Update

The Board of Ormonde (LON:ORM) is pleased to provide an update of construction activities for the Barruecopardo Project in Salamanca, Spain (“Barruecopardo” or the “Project”).
Following a period of review of the construction schedule, the Board of the Project company, Saloro SLU (“Saloro”), has authorised the issuance of outstanding approvals on

Falco Resources Appoints Bryan Coates to Board

Falco Resources Appoints Bryan Coates to Board

Falco Resources Ltd. (TSXV:FPC) has made the following appointments: Bryan A. Coates, president of Osisko Gold Royalties Ltd., will be joining the board of directors and will chair a newly formed finance committee of the board of directors. Hélène Cartier, who currently sits on the Board of Directors, will join

The Potential of Transdermal Drug Delivery

The Potential of Transdermal Drug Delivery

Drugs with low oral bioavailability risk failure in clinical trial: minimal absorption, after all, can translate to reduced efficacy. As a result, pharmaceutical companies look for alternative drug delivery methods.

Falco Commences 40,000 Metre Drill Program

Falco Commences 40,000 Metre Drill Program

Falco Resources Ltd. (TSX.V: FPC) is pleased to announce that it is initiating exploration activities on its large 668 square kilometre land package in the Rouyn-Noranda Camp, which surrounds it’s 100% owned Horne 5 Project. The planned 40,000 metre exploration drill campaign is part of a $10 million budget

Immunovaccine’s Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug

Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the UHN’s Princess Margaret Cancer Centre (PM) will conduct a Phase 2 clinical trial to evaluate the use of a combination of immunotherapies from Immunovaccine and Merck (known as MSD outside the United States and Canada).

Clinical investigators will assess

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network